Bryan Nicolalde

About Bryan Nicolalde

Bryan Nicolalde, With an exceptional h-index of 5 and a recent h-index of 5 (since 2020), a distinguished researcher at Universidad San Francisco de Quito, specializes in the field of Medicina basada en evidencia, Educación médica, Medicina Interna.

His recent articles reflect a diverse array of research interests and contributions to the field:

Rhupus syndrome in the pediatric population: A comprehensive systematic literature review.

Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study

Efficacy of Antiobesity Medications in Patients With Celiac Disease on a Gluten-free Diet: A Retrospective Matched Cohort Study

Mo1917 PREVIOUS ANTI-OBESITY MEDICATION INFLUENCES THE WEIGHT LOSS OUTCOMES OF SEMAGLUTIDE TREATMENT FOR OBESITY

Mo1915 REAL-WORLD WEIGHT LOSS AND METABOLIC PARAMETERS OUTCOMES OF SEMAGLUTIDE: A 1-YEAR MULTI-SITE STUDY

Mo1916 SEMAGLUTIDE WEIGHT LOSS AND METABOLIC PARAMETERS OUTCOMES IN PATIENTS AFTER BARIATRIC SURGERIES: A 1-YEAR MULTI-CENTERED STUDY

Mo1921 EFFICACY OF ANTIOBESITY MEDICATIONS ON WEIGHT LOSS OUTCOMES IN PATIENTS WITH CELIAC DISEASE

702 WEIGHT LOSS OUTCOMES WITH SEMAGLUTIDE BASED ON DIABETES STATUS AND SEVERITY USING THE INDIVIDUALIZED METABOLIC SURGERY SCORE

Bryan Nicolalde Information

University

Position

Profesor asistencial

Citations(all)

176

Citations(since 2020)

174

Cited By

42

hIndex(all)

5

hIndex(since 2020)

5

i10Index(all)

2

i10Index(since 2020)

2

Email

University Profile Page

Google Scholar

Bryan Nicolalde Skills & Research Interests

Medicina basada en evidencia

Educación médica

Medicina Interna

Top articles of Bryan Nicolalde

Rhupus syndrome in the pediatric population: A comprehensive systematic literature review.

2024/4/5

Bryan Nicolalde
Bryan Nicolalde

H-Index: 3

Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study

International Journal of Obesity

2024/2/1

Efficacy of Antiobesity Medications in Patients With Celiac Disease on a Gluten-free Diet: A Retrospective Matched Cohort Study

Journal of Clinical Gastroenterology

2023/9/28

Mo1917 PREVIOUS ANTI-OBESITY MEDICATION INFLUENCES THE WEIGHT LOSS OUTCOMES OF SEMAGLUTIDE TREATMENT FOR OBESITY

Gastroenterology

2023/5/1

Bryan Nicolalde
Bryan Nicolalde

H-Index: 3

Khushboo Gala
Khushboo Gala

H-Index: 2

Mo1915 REAL-WORLD WEIGHT LOSS AND METABOLIC PARAMETERS OUTCOMES OF SEMAGLUTIDE: A 1-YEAR MULTI-SITE STUDY

Gastroenterology

2023/5/1

Mo1916 SEMAGLUTIDE WEIGHT LOSS AND METABOLIC PARAMETERS OUTCOMES IN PATIENTS AFTER BARIATRIC SURGERIES: A 1-YEAR MULTI-CENTERED STUDY

Gastroenterology

2023/5/1

Bryan Nicolalde
Bryan Nicolalde

H-Index: 3

Khushboo Gala
Khushboo Gala

H-Index: 2

Mo1921 EFFICACY OF ANTIOBESITY MEDICATIONS ON WEIGHT LOSS OUTCOMES IN PATIENTS WITH CELIAC DISEASE

Gastroenterology

2023/5/1

Khushboo Gala
Khushboo Gala

H-Index: 2

Bryan Nicolalde
Bryan Nicolalde

H-Index: 3

702 WEIGHT LOSS OUTCOMES WITH SEMAGLUTIDE BASED ON DIABETES STATUS AND SEVERITY USING THE INDIVIDUALIZED METABOLIC SURGERY SCORE

Gastroenterology

2023/5/1

Bryan Nicolalde
Bryan Nicolalde

H-Index: 3

Khushboo Gala
Khushboo Gala

H-Index: 2

Su1910 ENDOSCOPIC REVISION OF PRIMARY BARIATRIC AND ENDOBARIATRIC PROCEDURES: COMPARISON OF WEIGHT LOSS OUTCOMES AND SAFETY

Gastroenterology

2023/5/1

Khushboo Gala
Khushboo Gala

H-Index: 2

Bryan Nicolalde
Bryan Nicolalde

H-Index: 3

Su1918 EFFICACY OF ANTIOBESITY MEDICATIONS ON WEIGHT LOSS OUTCOMES IN PATIENTS WITH A TRANSORAL OUTLET REDUCTION AFTER ROUX-EN-Y GASTRIC BYPASS SURGERY

Gastroenterology

2023/5/1

Khushboo Gala
Khushboo Gala

H-Index: 2

Bryan Nicolalde
Bryan Nicolalde

H-Index: 3

840 IMPACT OF HETEROZYGOUS GENETIC VARIANTS IN THE LEPTIN-MELANOCORTIN PATHWAY ON WEIGHT LOSS OUTCOMES FOLLOWING ENDOSCOPIC TRANSORAL OUTLET REDUCTION AFTER ROUX-EN-Y GASTRIC …

Gastroenterology

2023/5/1

Khushboo Gala
Khushboo Gala

H-Index: 2

Bryan Nicolalde
Bryan Nicolalde

H-Index: 3

The Effect of Altitude on Cardiovascular Disease Mortality: Insights From a National Database in Ecuador

Circulation

2023/11/7

Bryan Nicolalde
Bryan Nicolalde

H-Index: 3

S1485 Semaglutide Outcomes in Non-Alcoholic Fatty Liver Disease: A Multi-Centered Real-World Study

Official journal of the American College of Gastroenterology| ACG

2023/10/1

S1648 Cardiovascular Disease Risk Improvement With Semaglutide in Patients With Obesity: A Multi-Centered Study

Official journal of the American College of Gastroenterology| ACG

2023/10/1

FRI077 Efficacy Of Anti-obesity Medications Among Breast Cancer Survivors Taking Aromatase Inhibitors

Journal of the Endocrine Society

2023/10

Bryan Nicolalde
Bryan Nicolalde

H-Index: 3

FRI078 Real-World Weight Loss Outcomes And Safety Of Tirzepatide, A Novel Dual GIP And GLP-1 Receptor Agonist

Journal of the Endocrine Society

2023/10

Bryan Nicolalde
Bryan Nicolalde

H-Index: 3

Cognitive impairment or dementia in post-acute COVID-19 syndrome. Two suspects and a perfect detective: positron emission tomography (PET) scan

European Neuropsychopharmacology

2022/8

Bryan Nicolalde
Bryan Nicolalde

H-Index: 3

The time to act: Early recommendations on patient care for psychiatric disorders in post-acute COVID-19 syndrome (PDPACS); Response to Llach and Ammella´ s letter to the editor …

European Neuropsychopharmacology

2022/7

Bryan Nicolalde
Bryan Nicolalde

H-Index: 3

Psychiatric disorders in Post-acute COVID-syndrome (PDPACS): recommendations for health care professionals

European Neuropsychopharmacology

2022/5

Bryan Nicolalde
Bryan Nicolalde

H-Index: 3

Scientific literacy and preferred resources used by latin American medical students during the COVID-19 pandemic: a multinational survey

F1000Research

2022

Bryan Nicolalde
Bryan Nicolalde

H-Index: 3

Enrique Teran
Enrique Teran

H-Index: 17

See List of Professors in Bryan Nicolalde University(Universidad San Francisco de Quito)

Co-Authors

academic-engine